Kang Z - Search Results

1

Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response.

Kang Z, Chen JJ, Yu Y, Li B, Sun SY, Zhang B, Cao L. Kang Z, et al. Clin Cancer Res. 2011 May 15;17(10):3181-92. doi: 10.1158/1078-0432.CCR-10-2874. Epub 2011 Mar 8. Clin Cancer Res. 2011. PMID: 21385927 Free PMC article.

2

Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma.

Kang Z, Sun SY, Cao L. Kang Z, et al. ISRN Oncol. 2012;2012:395952. doi: 10.5402/2012/395952. Epub 2012 Apr 17. ISRN Oncol. 2012. PMID: 22577581 Free PMC article.

3

Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma.

Kang Z, Goldstein SD, Yu Y, Meltzer PS, Loeb DM, Cao L. Kang Z, et al. Br J Cancer. 2015 Sep 15;113(6):894-901. doi: 10.1038/bjc.2015.298. Epub 2015 Aug 20. Br J Cancer. 2015. PMID: 26291055 Free PMC article.

4

Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L).

Mayeenuddin LH, Yu Y, Kang Z, Helman LJ, Cao L. Mayeenuddin LH, et al. Among authors: kang z. Oncogene. 2010 Dec 2;29(48):6367-77. doi: 10.1038/onc.2010.364. Epub 2010 Sep 6. Oncogene. 2010. PMID: 20818434 Free PMC article.

5

Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.

Harouaka R, Kang Z, Zheng SY, Cao L. Harouaka R, et al. Among authors: kang z. Pharmacol Ther. 2014 Feb;141(2):209-21. doi: 10.1016/j.pharmthera.2013.10.004. Epub 2013 Oct 14. Pharmacol Ther. 2014. PMID: 24134902 Free PMC article. Review.

6

Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring.

Kang Z, Stevanović S, Hinrichs CS, Cao L. Kang Z, et al. Clin Cancer Res. 2017 Nov 15;23(22):6856-6862. doi: 10.1158/1078-0432.CCR-17-1553. Epub 2017 Sep 12. Clin Cancer Res. 2017. PMID: 28899967 Free PMC article.

7

Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors.

Strauss J, Heery CR, Schlom J, Madan RA, Cao L, Kang Z, Lamping E, Marté JL, Donahue RN, Grenga I, Cordes L, Christensen O, Mahnke L, Helwig C, Gulley JL. Strauss J, et al. Among authors: kang z. Clin Cancer Res. 2018 Mar 15;24(6):1287-1295. doi: 10.1158/1078-0432.CCR-17-2653. Epub 2018 Jan 3. Clin Cancer Res. 2018. PMID: 29298798 Free PMC article. Clinical Trial.

8

Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma.

Kang Z, Yu Y, Zhu YJ, Davis S, Walker R, Meltzer PS, Helman LJ, Cao L. Kang Z, et al. Oncogene. 2014 Dec 11;33(50):5697-705. doi: 10.1038/onc.2013.509. Epub 2013 Dec 2. Oncogene. 2014. PMID: 24292683 Free PMC article.

9

Elevated Serum Megakaryocyte Potentiating Factor as a Predictor of Poor Survival in Patients with Mesothelioma and Primary Lung Cancer.

Yu Y, Ryan BM, Thomas A, Morrow B, Zhang J, Kang Z, Zingone A, Onda M, Hassan R, Pastan I, Cao L. Yu Y, et al. Among authors: kang z. J Appl Lab Med. 2018 Sep;3(2):166-177. doi: 10.1373/jalm.2017.025015. J Appl Lab Med. 2018. PMID: 30370398 Free PMC article.

10

A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer.

Do K, Cao L, Kang Z, Turkbey B, Lindenberg ML, Larkins E, Holkova B, Steinberg SM, Raffeld M, Peer CJ, Figg WD, Eugeni M, Jacobs P, Choyke P, Wright JJ, Doroshow JH, Kummar S. Do K, et al. Among authors: kang z. Clin Colorectal Cancer. 2015 Sep;14(3):154-61. doi: 10.1016/j.clcc.2015.02.007. Epub 2015 Mar 7. Clin Colorectal Cancer. 2015. PMID: 25861837 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,713 results

Search Page

Filters